Australia markets closed

Cell Source, Inc. (CLCS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0008+0.0006 (+300.00%)
At close: 12:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,684
1,996
1,323
998.554
2,630
Selling general and administrative
2,705
2,179
2,695
2,639
1,175
Total operating expenses
4,389
4,175
4,019
3,638
3,805
Operating income or loss
-4,389
-4,175
-4,019
-3,638
-3,805
Interest expense
1,261
992.415
1,361
937.406
307.947
Total other income/expenses net
-
-
-93.16
15.277
-362.347
Income before tax
-5,609
-5,168
-5,472
-4,560
-4,475
Income from continuing operations
-5,609
-5,168
-5,472
-4,560
-4,475
Net income
-5,609
-5,168
-5,472
-4,560
-4,475
Net income available to common shareholders
-6,804
-6,325
-6,446
-5,438
-5,217
Basic EPS
-0.18
-0.18
-0.19
-0.19
-0.18
Diluted EPS
-0.18
-0.18
-0.19
-0.19
-0.18
Basic average shares
36,934
34,836
33,117
29,099
28,329
Diluted average shares
36,934
34,836
33,117
29,099
28,329